[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
November 3, 1999

Infections From Endoscopes

Author Affiliations

Not Available

Not Available

JAMA. 1999;282(17):1613. doi:10.1001/jama.282.17.1613-JFD90009-3-1

The FDA and Centers for Disease Control and Prevention (CDC) have alerted hospital personnel and practitioners to incidents in which patients developed serious infections after being examined with bronchoscopes that apparently were inadequately reprocessed in an automated endoscope reprocessor (AER).

Investigation of the incidents by the CDC revealed inconsistencies between the reprocessing instructions of the bronchoscope manufacturer and the AER manufacturer and showed that some bronchoscopes were inadequately reprocessed because of the use of inappropriate channel connectors with the AER. The FDA has received reports that some people use AERs for endoscopes that should not be reprocessed in those devices.

First Page Preview View Large
First page PDF preview
First page PDF preview